Wilhelm Michel
Director/Board Member chez ADVAL TECH HOLDING AG
Fortune : 4 373 M $ au 31/03/2024
Profil
Wilhelm Michel est un entrepreneur et un homme d'affaires suisse qui a fondé 5 sociétés, dont Ypsomed Holding AG, Disetronic Holding AG et la Fondation Diabetes Center Berne : Ypsomed Holding AG, Disetronic Holding AG et Diabetes Center Berne Foundation et qui a été à la tête de 11 sociétés différentes. Actuellement, le Dr Michel occupe le poste de président non exécutif d'Ypsomed Holding AG (qu'il a fondée en 2003), de président du conseil de surveillance de Fertility Biotech AG (qu'il a fondée en 2016), de président du conseil d'administration de la Fondation Diabetes Center Berne (qu'il a fondée en 2017), de président du conseil de surveillance d'Adval Tech Holding (Allemagne) GmbH et de président du conseil de surveillance de Techpharma Management AG. Le Dr Michel est également membre du conseil d'administration de BV Holding AG (ancien président) et de Faes Bau AG. Au cours de sa carrière, le Dr Michel a occupé les fonctions de président d'Adval Tech Holding AG, de directeur général de Novo Nordisk Pharma AG, de propriétaire du musée Franz Gertsch, de président et directeur général de Disetronic Holding AG (qu'il a fondée en 1984), de président et directeur général de Disetronic Medical Systems AG, de président de Finox AG (qu'il a fondée en 2007) et de propriétaire de Finox Beteiligungen AG.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
YPSOMED HOLDING AG
73,79% | 31/03/2023 | 10 072 139 ( 73,79% ) | 4 031 M $ | 31/03/2024 |
SKAN GROUP AG
15,00% | 19/09/2023 | 3 371 697 ( 15,00% ) | 319 M $ | 31/03/2024 |
ADVAL TECH HOLDING AG
28,90% | 31/12/2022 | 210 970 ( 28,90% ) | 23 M $ | 31/03/2024 |
Postes actifs de Wilhelm Michel
Sociétés | Poste | Début |
---|---|---|
ADVAL TECH HOLDING AG | Director/Board Member | 20/05/2021 |
BV Holding AG
BV Holding AG Investment ManagersFinance BV Holding AG engages in the provision of equity financing. It invests in other companies with the goal of value creation. The company was founded on April 8, 1997 and is headquartered in Gumligen, Switzerland. | Director/Board Member | 01/03/2008 |
Faes Bau AG | Director/Board Member | 26/11/2010 |
Techpharma Management AG
Techpharma Management AG Financial ConglomeratesFinance Techpharma Management AG engages in the provision of services to affiliated firms and the operation of hotels. Its services include the provision of real estate for use, and advice on management, financing and investment issues, as well as the administration of hotels and restaurants, in particular the Hotel Stadthaus, the Hotel Berchtold and the Restaurant Schützenhaus in Burgdorf. The company was founded on May 4, 2000 and is headquartered in Burgdorf, Switzerland. | Chairman | - |
Diabetes Center Berne Foundation | Founder | 01/06/2017 |
Adval Tech Holding (Germany) GmbH
Adval Tech Holding (Germany) GmbH Financial ConglomeratesFinance Part of Adval Tech Holding AG, Adval Tech Holding (Germany) GmbH provides investment services. The private company is based in Endingen am Kaiserstuhl, Germany. René Rothen has been the CEO of the German company since 2012. | Chairman | - |
Anciens postes connus de Wilhelm Michel
Sociétés | Poste | Fin |
---|---|---|
YPSOMED HOLDING AG | Founder | 29/06/2022 |
Finox Biotech AG
Finox Biotech AG Medical/Nursing ServicesHealth Services Finox AG specializes in developing fertility drugs. Its products include BEMFOLA, a recombinant-human follicle-stimulating hormone. The company was founded by Michel Wilhelm in 2007 and is headquartered in Burgdorf, Switzerland. | Founder | 01/07/2016 |
Finox Beteiligungen AG | Corporate Officer/Principal | 16/09/2013 |
░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ADVAL TECH HOLDING AG | Producer Manufacturing |
YPSOMED HOLDING AG | Health Technology |
Entreprise privées | 13 |
---|---|
Disetronic Holding AG
Disetronic Holding AG Medical SpecialtiesHealth Technology Disetronic Holding AG manufactured medical products for treatment of diabetes. The company infusion business was integrated into the Roche Diabetes Care Business Area within the Roche Diagnostics Division. Founded in 1990, the company was headquartered in Burgdorf, Switzerland. | Health Technology |
Techpharma Management AG
Techpharma Management AG Financial ConglomeratesFinance Techpharma Management AG engages in the provision of services to affiliated firms and the operation of hotels. Its services include the provision of real estate for use, and advice on management, financing and investment issues, as well as the administration of hotels and restaurants, in particular the Hotel Stadthaus, the Hotel Berchtold and the Restaurant Schützenhaus in Burgdorf. The company was founded on May 4, 2000 and is headquartered in Burgdorf, Switzerland. | Finance |
Finox Beteiligungen AG | Finance |
Ziemer Group AG
Ziemer Group AG Medical SpecialtiesHealth Technology Ziemer Group AG develops, manufactures, and markets diagnostic and surgical ophthalmic products. Its products include FEMTO LDV, AMADEUS, GALILEI and PASCAL. The company was founded by Frank Ziemer in 1998 and is headquartered in Port, Switzerland. | Health Technology |
BV Holding AG
BV Holding AG Investment ManagersFinance BV Holding AG engages in the provision of equity financing. It invests in other companies with the goal of value creation. The company was founded on April 8, 1997 and is headquartered in Gumligen, Switzerland. | Finance |
Disetronic Medical Systems AG | |
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |
Faes Bau AG | |
Museum Franz Gertsch | |
Finox Biotech AG
Finox Biotech AG Medical/Nursing ServicesHealth Services Finox AG specializes in developing fertility drugs. Its products include BEMFOLA, a recombinant-human follicle-stimulating hormone. The company was founded by Michel Wilhelm in 2007 and is headquartered in Burgdorf, Switzerland. | Health Services |
Fertility Biotech AG
Fertility Biotech AG BiotechnologyHealth Technology Fertility Biotech AG is a holding company, which engages in the development, production, and distribution of medicines. The company was founded on June 7, 2016 and is headquartered in Burgdorf, Switzerland. | Health Technology |
Diabetes Center Berne Foundation | |
Adval Tech Holding (Germany) GmbH
Adval Tech Holding (Germany) GmbH Financial ConglomeratesFinance Part of Adval Tech Holding AG, Adval Tech Holding (Germany) GmbH provides investment services. The private company is based in Endingen am Kaiserstuhl, Germany. René Rothen has been the CEO of the German company since 2012. | Finance |